‘‘(3) the training of health care professionals 
and health educators to make them aware of the 
high rates of chronic hepatitis B in certain adult 
ethnic populations, and the importance of preven-
tion, detection, and medical management of hepatitis 
B and of liver cancer screening; 
‘‘(4) the development and distribution of health 
education curricula (including information relating 
to the special needs of individuals infected with hep-
atitis B, such as the importance of prevention and 
early intervention, regular monitoring, and appro-
priate treatment and liver cancer screening) for indi-
viduals providing hepatitis B counseling; 
‘‘(5) support for the implementation curricula 
described in paragraph (4) by State and local public 
health agencies; and 
‘‘(6) the provision of grants for the inclusion of 
viral hepatitis and liver wellness education curricula 
in elementary and secondary school health education 
programs. 
‘‘(c) EPIDEMIOLOGICAL SURVEILLANCE.— 
‘‘(1) IN
GENERAL.—The Secretary, acting 
through the Director of the Centers for Disease 
Control and Prevention, shall support the establish-
ment and maintenance of a national chronic and
acute hepatitis B surveillance program, in order to 
identify— 
‘‘(A) trends in the incidence of acute and 
chronic hepatitis B; 
‘‘(B) trends in the prevalence of acute and 
chronic hepatitis B infection among groups that 
may be disproportionately affected by hepatitis 
B; and 
‘‘(C) liver cancer and end stage liver dis-
ease incidence and deaths, caused by chronic 
hepatitis B in the various ethnic populations. 
‘‘(2) SEROPREVALENCE
AND
LIVER
CANCER 
STUDIES.—The Secretary, acting through the Direc-
tor of the Centers for Disease Control and Preven-
tion, shall prepare a report outlining the population- 
based seroprevalence studies currently under way, 
future planned studies, the criteria involved in deter-
mining which seroprevalence studies to conduct, 
defer, or suspend, and the scope of those studies, the 
economic and clinical impact of hepatitis B, and the 
impact of hepatitis B on quality of life. Not later 
than one year after the date of enactment of this 
part, the Secretary shall submit the report to the 
Committee on Energy and Commerce of the House
of Representatives and the Committee on Health, 
Education, Labor, and Pensions of the Senate. 
‘‘(3) CONFIDENTIALITY.—The Secretary shall 
not disclose any individually identifiable information 
identified under paragraph (1) or derived through 
studies under paragraph (2). 
‘‘(d) RESEARCH.—The Secretary, acting through the 
Director of the Centers for Disease Control and Preven-
tion, the Director of the National Cancer Institute, and 
the Director of the National Institutes of Health, shall— 
‘‘(1) conduct community-based research to de-
velop, implement, and evaluate best practices for 
hepatitis B prevention especially in the ethnic popu-
lations with high rates of chronic hepatitis B and 
other high-risk groups; 
‘‘(2) conduct research on hepatitis B natural 
history, pathophysiology, improved treatments, and 
non-invasive tests that helps to predict the risk of 
progression to liver cirrhosis and liver cancer; and 
‘‘(3) conduct research that will lead to better 
non-invasive or blood tests to screen for liver cancer, 
and more effective treatments of liver cancer caused 
by chronic hepatitis. 
‘‘(e) EXPANDED SUPPORT FOR UNDERSERVED AND 
DISPROPORTIONATELY AFFECTED POPULATIONS CHRON-
ICALLY INFECTED WITH HBV.—In carrying out this sec-
tion, the Secretary shall give priority to individuals with 
limited access to health education, testing, and health care 
services and groups that may be disproportionately af-
fected by hepatitis B, including populations such as Asian 
Americans with a high incidence of chronic hepatitis B 
and liver cancer.’’. 
Æ